期刊
EXPERIMENTAL CELL RESEARCH
卷 319, 期 4, 页码 506-516出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2012.11.005
关键词
Transcription factor STAT3; DNA damaging chemotherapeutics; TNF alpha; NK cytotoxicity; STAT3-NF kappa B crosstalk
资金
- Polish Ministry of Science and Higher Education [M345/N-INCA/2008]
- European Science Foundation (ESF)
Transcription factor STAT3 (Signal Transducers and Activators of Transcription 3) is persistently active in human tumors and may contribute to tumor progression. Inhibition of STAT3 expression/activity could be a good strategy to modulate tumor cell survival and responses to cancer chemotherapeutics or immune cytotoxicity. We silenced STAT3 expression in human A549 lung cancer cells to elucidate its role in cell survival and resistance to chemotherapeutics, TNF alpha and natural killer (NK)-mediated cytotoxicity. We demonstrate that STAT3 is not essential for basal survival and proliferation of A549 cancer cells. Stable silencing of STAT3 expression sensitized A549 cells to DNA damaging chemotherapeutics doxorubicin and cisplatin in a p53-independent manner. Sensitization to DNA damage-inducing chemotherapeutics could be due to down-regulation of the BcI-xL expression in STAT3 depleted cells. In contrast, knockdown of STAT3 in cancer cells did not modulate responses to TNF alpha and NK-mediated cytotoxicity. We found that STAT3 depletion increased the NF kappa B activity likely providing the compensatory, pro-survival signal. The treatment with INF alpha, but not doxorubicin, enhanced this effect. We conclude that STAT3 is not crucial for the control of basal cell proliferation and survival of lung carcinoma cells but modulates susceptibility to DNA damaging chemotherapeutics by regulation of intrinsic pro-survival pathways. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据